Out of 11 genes associated with the non-homologous end joining, 4 (i.e., XRCC4, PRKDC, FEN1, and DCLRE1C) display significantly higher expressions in OS tumor samples than normal controls while DNTT has no detectable expression in normal controls (see Supplementary Fig. S1d). This evidence concerns the gene PRKDC and neoplasm.